SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Strong Long who wrote (1900)4/29/2016 3:35:07 PM
From: mokelumne river  Read Replies (1) of 2026
 
SL, I have the same nagging concerns. One thing we have to remember, very few if any medical doctors in the US (except Dr. Irwin Goldstein who specializes in sexual health and is an advocate) is going to comment on Vitaros efficacy one way or another if it is not FDA approved. If the FDA approves it, there will be press here and it will be stated that Vitaros has been approved and prescribed for years in Europe without adverse side effects. Presentations at conferences in the US will have more relevance, particularly for urologists. We are one year away from the FDA binary event.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News